Serveur d'exploration sur la COVID en France - Analysis (France)

Index « Auteurs » - entrée « V. Gendrin »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
V. Estrade < V. Gendrin < V. Jardon  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
000067 (2020) T. Klopfenstein [France] ; S. Zayet [France] ; A. Lohse [France] ; J-C Balblanc [France] ; J. Badie [France] ; P-Y Royer [France] ; L. Toko [France] ; C. Mezher [France] ; N J Kadiane-Oussou [France] ; M. Bossert [France] ; A-M Bozgan [France] ; A. Charpentier [France] ; M-F Roux [France] ; R. Contreras [France] ; I. Mazurier [France] ; P. Dussert [France] ; V. Gendrin [France] ; T. Conrozier [France]Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients.
000160 (2020) T. Klopfenstein [France] ; N J Kadiane-Oussou [France] ; L. Toko [France] ; P-Y Royer [France] ; Q. Lepiller [France] ; V. Gendrin [France] ; S. Zayet [France]Features of anosmia in COVID-19.

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Adult (MeSH)
2Aged (MeSH)
2Comorbidity (MeSH)
2Coronavirus Infections (epidemiology)
2Coronavirus Infections (pathology)
2Female (MeSH)
2France (epidemiology)
2Humans (MeSH)
2Male (MeSH)
2Middle Aged (MeSH)
2Pandemics (MeSH)
2Pneumonia, Viral (epidemiology)
2Pneumonia, Viral (pathology)
2Retrospective Studies (MeSH)
2Severity of Illness Index (MeSH)
1Adolescent (MeSH)
1Aged, 80 and over (MeSH)
1Antibodies, Monoclonal, Humanized (therapeutic use)
1Betacoronavirus (drug effects)
1Betacoronavirus (immunology)
1Betacoronavirus (physiology)
1Case-Control Studies (MeSH)
1Cohort Studies (MeSH)
1Coronavirus Infections (complications)
1Coronavirus Infections (drug therapy)
1Coronavirus Infections (mortality)
1Coronavirus Infections (therapy)
1Critical Illness (epidemiology)
1Critical Illness (mortality)
1Intensive Care Units (statistics & numerical data)
1Mortality (MeSH)
1Olfaction Disorders (epidemiology)
1Olfaction Disorders (therapy)
1Olfaction Disorders (virology)
1Oxygen Inhalation Therapy (MeSH)
1Patient Admission (statistics & numerical data)
1Pneumonia (epidemiology)
1Pneumonia (physiopathology)
1Pneumonia (therapy)
1Pneumonia (virology)
1Pneumonia, Viral (complications)
1Pneumonia, Viral (drug therapy)
1Pneumonia, Viral (mortality)
1Pneumonia, Viral (therapy)
1Prevalence (MeSH)
1Respiratory Function Tests (MeSH)
1Time Factors (MeSH)
1Treatment Outcome (MeSH)
1Young Adult (MeSH)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "V. Gendrin" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "V. Gendrin" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    V. Gendrin
}}

Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021